申请人:Industry-University Cooperation Foundation Hanyang University Erica Campus
公开号:US20190284221A1
公开(公告)日:2019-09-19
The present invention relates to a TRIS- or neopentyl glycol-based amphipathic compound, a method of preparing the same, and a method of extracting, solubilizing, stabilizing, or crystallizing a membrane protein using the same. By using the TRIS- or neopentyl glycol-based compound according to the present invention, a superior membrane protein solubilization effect is exhibited, a membrane protein can be stably stored for a long time in an aqueous solution, and the structural fluidity of the membrane protein can be excellently maintained. Accordingly, the TRIS- or neopentyl glycol-based compound can be utilized in analyzing functions and structures of membrane proteins. Membrane protein structure and function analysis is currently one of the most attractive fields of research in biology and chemistry. Since more than half of the new drugs under development target membrane proteins, the compound can be applied to membrane protein structure research closely related to drug discovery.
本发明涉及一种基于TRIS或新戊二醇的两性分子化合物,其制备方法,以及使用该化合物提取、溶解、稳定或结晶膜蛋白的方法。通过使用本发明中的TRIS或新戊二醇化合物,可以展示出卓越的膜蛋白溶解效果,可以在水溶液中稳定存储膜蛋白,并且可以优秀地维持膜蛋白的结构流动性。因此,TRIS或新戊二醇化合物可以用于分析膜蛋白的功能和结构。膜蛋白结构和功能分析目前是生物和化学研究中最具吸引力的领域之一。由于超过一半的新药开发针对膜蛋白,因此该化合物可以应用于与药物发现密切相关的膜蛋白结构研究。